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Variable phenotype in females with the samemutation
could be explained by variations in expression due to
differences in X inactivation among families, as sug-
gested by Aradhya (2000). If so, an X-inactivation study
could be helpful in predicting phenotypic outcome in a
female heterozygote with the mutation. However, the
proband in the family described here (HED-ID pheno-
type) and the female heterozygote in family XL344 (IP-
like phenotype; Aradhya et al. 2001) yielded the same
random X-inactivation pattern. We therefore suspect
that an X-inactivation study would have limited predic-
tive value.
To summarize, hypomorphic mutations in theNEMO
gene can lead to the devastating HED-ID phenotype in
female heterozygotes as well as males. The very broad
phenotypic spectrum of female heterozygotes, ranging
from normal to overt immunodeficiency, poses a chal-
lenge during counseling of families with HED-ID.
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Reply to Kosaki et al.
To the Editor:
The letter from Kosaki et al. (2001 [in this issue]) reports
the first instance of immunodeficiency in a female het-
erozygous for a hypomorphic mutation of the X-linked
NEMO gene. NEMO hypomorphic mutations result, in
males, in the disorder hypohidrotic ectodermal dysplasia
with immunodeficiency (HED-ID) (Zonana et al. 2000;
Aradhya et al. 2001; Doffinger et al. 2001; Jain et al.
2001). In the 17 families previously reported, only males
have had clinical immunodeficiency. As expected, owing
to Lyonization, carrier females either were normal or
had defects of their teeth, skin, or hair. A single female
carrier, heterozygous for the same mutation reported in
the family studied by Kosaki et al., had an elevated im-
munoglobulin A level (Zonana et al. 2000) but did not
have immunodeficiency.
Null mutation of the NEMO gene generally results in
prenatal lethality in hemizygous males and in inconti-
nentia pigmenti in heterozygous females. Affected fe-
males are immunologically normal, presumably owing
to preferential survival and proliferation of cells ex-
pressing the normal allele (skewed X inactivation). Fe-
male carriers with hypomorphic mutations have shown
both random and skewed X inactivation, indicating that
at least some of the mutations do not affect T- and B-
cell survival or proliferation (Aradhya et al. 2001; Dof-
finger et al. 2001; Jain et al. 2001). Rarely, females can
fully manifest X-linked recessive disorders, including
other X-linked immunodeficiencies, such as Wiskott-Al-
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drich syndrome (Puck and Willard 1998). However, in
contrast to the patient reported by Kosaki et al., cases
not due to cytogenetic abnormalities demonstrate
skewed X inactivation, presumably of cells expressing
the mutant allele. In these instances, the mutations do
not impair cell proliferation or survival but still do cause
cellular dysfunction.
It is difficult to reconcile Kosaki et al.’s finding of
random X inactivation in the peripheral blood leuko-
cytes with their patient’s clinical manifestations. We
would expect to find skewed X inactivation in which
the X chromosome expressing the mutant allele is pre-
dominant. It is possible that a functionally important
subset of B or T cells (Jain et al. 2001) would have
displayed skewed X inactivation if Kosaki et al. had
sorted the leukocytes into separate populations before
analysis. Another remote possibility is that, unlike the
patient’s presumably heterozygous mother and sister,
who had ectodermal findings but no immunodeficiency,
the patient had a loss of her normal NEMO allele. The
existence of a highly homologous NEMO pseudogene
on the X chromosome makes it very difficult to distin-
guish hemizygosity from true heterozygosity.
Kosaki et al.’s findings are unique, but, as in other
examples, fully manifesting females with X-linked re-
cessive disorders—such as Duchenne muscular dystro-
phy and hemophilia B—usually represent rare events
(Puck and Willard 1998). Families should still be coun-
seled that generally, in HED-ID, only males manifest
clinically significant immunodeficiency. Further cases of
immunodeficient females with HED-ID must be de-
scribed before such counseling should be altered.
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